Joint Preservation Therapy Solutions in Tucson, AZ

How Tucson is not Florida First Coast

Adult arthritis here is 23.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 11.5% of adults in Tucson have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. joint preservation therapy inventory is national; utilization is JF-local.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 23.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 15.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Arizona.
• PRP is autologous and not an HCT/P 361 allograft, but payers in JF still expect diagnosis-driven documentation. A 1-minute spin does not replace a medically necessary indication or a procedure note.
• In a city of 500k–1M, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Tucson street address.

Payer geography for Tucson, AZ

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Tucson is 11.5% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic